Compare QURE & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QURE | ACHC |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | 2013 | 2011 |
| Metric | QURE | ACHC |
|---|---|---|
| Price | $24.11 | $37.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $59.78 | $39.07 |
| AVG Volume (30 Days) | 1.7M | ★ 2.2M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | $13,107,000.00 | ★ $3,312,769,000.00 |
| Revenue This Year | $44.21 | $4.17 |
| Revenue Next Year | $398.45 | $6.10 |
| P/E Ratio | ★ N/A | $70.41 |
| Revenue Growth | N/A | ★ 5.04 |
| 52 Week Low | $8.73 | $11.43 |
| 52 Week High | $51.72 | $39.70 |
| Indicator | QURE | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 71.86 |
| Support Level | $20.63 | $26.70 |
| Resistance Level | $26.01 | N/A |
| Average True Range (ATR) | 1.93 | 1.99 |
| MACD | 0.68 | 0.68 |
| Stochastic Oscillator | 57.62 | 81.27 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.